Floatz logo

Flax Oil

Type2 Diabetes

Bogomolets National Medical UniversityN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Type2 Diabetes cohort.

Asset / SponsorPhaseRating
Alogliptin
Yonsei University
Phase 4BB
Vortioxetine
Todd Doyle
Phase 4BB
Pioglitazone
Yonsei University
Phase 4BB
Msdc-0602K
Cirius Therapeutics, Inc.
Phase 3B
Tangningtongluo Tablets
Guizhou Bailing Group Pharmaceutical Co Ltd
Phase 2CCC

View all 11 →

Same molecule, other indications

Flax Oil is also rated in:

abdominal obesity-metabolic syndromeDormant
D
Indicative ·
30 / 100
View asset →
bipolar disorderDormant
D
Indicative ·
30 / 100
View asset →
Insulin ResistanceDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →